Immunohistochemistry & Digital Pathology
Bringing a wealth of biomarker expertise in immunohistochemistry (IHC) assay development, validation and clinical sample analysis.
With a dedicated team of scientists, our laboratory has successfully supported multiple projects and possesses the capabilities to develop, optimize and validate IHC assays tailored to support your clinical trials and provide comprehensive data analysis and interpretation.
Elevate your clinical trials with unparalleled expertise in assay validation
Each assay is different and our IHC validation methods and processes ensure we are generating
high-quality data empowering you to move your trial forward with unwavering confidence.
- Standard histopathology
- IHC Single Biomarkers
Fluorescent in situ hybridization (FISH) & related in situ hybridization (ISH)
- 4-probe and dual-probe ISH testing
- Urothelial carcinoma testing for aneuploidy of chromosomes 3, 7, 17, or loss of both chromosomal 9p21 segments for diagnosis or to monitor patients
- HER2 dual-probe FISH and CISH